MUC1 and triple-negative breast carcinoma: Further study, however, has developed CAR T cells recognizing the altered glycosylated epitope within the MUC1 tandem repeat sequence (TAB004), which also demonstrated potent and selective antitumor activities in triple-negative breast cancer [19].